Cargando…

Promoter Hypermethylation of the EMP3 Gene in a Series of 229 Human Gliomas

The epithelial membrane protein 3 (EMP3) is a candidate tumor suppressor gene in the critical region 19q13.3 for several solid tumors, including tumors of the nervous systems. The aim of this study was to investigate the EMP3 promoter hypermethylation status in a series of 229 astrocytic and oligode...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mellai, Marta, Piazzi, Angela, Caldera, Valentina, Annovazzi, Laura, Monzeglio, Oriana, Senetta, Rebecca, Cassoni, Paola, Schiffer, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776370/ https://www.ncbi.nlm.nih.gov/pubmed/24083241 http://dx.doi.org/10.1155/2013/756302

Ejemplares similares

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres
por: Caldera, Valentina, et al.
Publicado: (2011)

Stem Cell Niches in Glioblastoma: A Neuropathological View
por: Schiffer, Davide, et al.
Publicado: (2014)

Stat3 Expression and Its Correlation with Proliferation and Apoptosis/Autophagy in Gliomas
por: Caldera, Valentina, et al.
Publicado: (2008)

Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?
por: Mellai, Marta, et al.
Publicado: (2015)

The Microenvironment in Gliomas: Phenotypic Expressions
por: Schiffer, Davide, et al.
Publicado: (2015)

SEL1L plays a major role in human malignant gliomas
por: Mellai, Marta, et al.
Publicado: (2019)

The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
por: Schiffer, Davide, et al.
Publicado: (2018)

Chondroitin Sulphate Proteoglycan 4 (NG2/CSPG4) Localization in Low- and High-Grade Gliomas
por: Mellai, Marta, et al.
Publicado: (2020)

Microglia immunophenotyping in gliomas
por: Annovazzi, Laura, et al.
Publicado: (2018)

Chemotherapeutic Drugs: DNA Damage and Repair in Glioblastoma
por: Annovazzi, Laura, et al.
Publicado: (2017)

The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment
por: ANNOVAZZI, LAURA, et al.
Publicado: (2015)

SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2015)

Correction: SEL1L SNP rs12435998, a predictor of glioblastoma survival and response to radio-chemotherapy
por: Mellai, Marta, et al.
Publicado: (2018)

Glioblastoma: Microenvironment and Niche Concept
por: Schiffer, Davide, et al.
Publicado: (2018)

Comparison among conventional and advanced MRI, (18)F-FDG PET/CT, phenotype and genotype in glioblastoma
por: Valentini, Maria Consuelo, et al.
Publicado: (2017)

Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors
por: Cha, Yoon Jin, et al.
Publicado: (2020)

Ki-67 proliferation index but not mitotic thresholds integrates the molecular prognostic stratification of lower grade gliomas
por: Duregon, Eleonora, et al.
Publicado: (2016)

Cancers of unknown primary origin: current perspectives and future therapeutic strategies
por: Stella, Giulia Maria, et al.
Publicado: (2012)

Caveolin-1 as a promoter of tumour spreading: when, how, where and why
por: Senetta, Rebecca, et al.
Publicado: (2013)

The lobular neoplasia enigma: management and prognosis in a long follow-up case series
por: Metovic, Jasna, et al.
Publicado: (2021)

Promoter Hypermethylation-mediated Inactivation of LRRC4 in Gliomas
por: Zhang, Zuping, et al.
Publicado: (2008)

Alu hypomethylation and MGMT hypermethylation in serum as biomarkers of glioma
por: Gong, Mingjie, et al.
Publicado: (2017)

PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma
por: Gao, Yuan-Feng, et al.
Publicado: (2016)

Phenformin and metformin inhibit growth and migration of LN229 glioma cells in vitro and in vivo
por: Wang, Yanmin, et al.
Publicado: (2018)

Description and status of the EMCI-EMP interface
por: Blasco Serrano, D, et al.
Publicado: (2022)

Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies
por: Clemente, Nausicaa, et al.
Publicado: (2018)

A “Weighted” Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors
por: Senetta, Rebecca, et al.
Publicado: (2013)

Meningeal carcinomatosis underdiagnosis and overestimation: incidence in a large consecutive and unselected population of breast cancer patients
por: Mittica, Gloria, et al.
Publicado: (2015)

Establishment of a nomogram with EMP3 for predicting clinical outcomes in patients with glioma: A bi‐center study
por: Zhang, Anke, et al.
Publicado: (2021)

Aberrant CpG Islands Hypermethylation Profiles in Malignant Gliomas
por: Kim, Kwang Ryeol, et al.
Publicado: (2014)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

EMP's first steps in the field of clinical trials
por: Goossens, Greetje
Publicado: (2010)

EMP2: Environmental Modelling and Prediction Platform
por: Ferrari, Anna
Publicado: (2022)

A novel empeROR of pancreatic malignancy
por: Peñuelas‐Haro, Irene, et al.
Publicado: (2023)

Sirt6 mRNA-incorporated endothelial microparticles (EMPs) attenuates DM patient-derived EMP-induced endothelial dysfunction
por: Jing, Tong, et al.
Publicado: (2017)

The Importance of Being “That” Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification
por: Gambella, Alessandro, et al.
Publicado: (2022)

Myeloablation-associated deletion of ORF4 in a human coronavirus 229E infection
por: Greninger, Alexander L., et al.
Publicado: (2017)

On the nuclear structure of $^{229}$Ra
por: García-Borge, M J, et al.
Publicado: (1991)

Octupole correlations in $^{229}Ra$
por: Fraile-Prieto, L M, et al.
Publicado: (1999)

The nuclear structure of $^{229}$Th
por: Gulda, K, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ejas56cr47dbkfh6ieenudhtth